Mark Hensley
COO
COO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Operating Officer | $372,212 | $4,307,500 |
| 2024 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Operating Officer | — | — |
| 2023 | Heron Therapeutics, Inc. /De/ (HRTX) | EVP, Chief Operating Officer | — | — |
Executive changes
Earnings-call appearances
-
Heron Therapeutics, Inc. /De/ Q1 FY2026 Earnings Call2026-05-11
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q4 FY2025 Earnings Call2026-02-26
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q3 FY2025 Earnings Call2025-11-04
Heron Therapeutics, Inc. /De/ (HRTX)
-
Heron Therapeutics, Inc. /De/ Q2 FY2025 Earnings Call2025-08-08
Heron Therapeutics, Inc. /De/ (HRTX)